Picture of Nexstim Oyj logo

NXTMH — Nexstim Oyj News Story

0.000.00%
fi flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Brief: Nexstim To License Technology To Us-Based Medical Technology Company Magnus Medical

Feb 14 (Reuters) - Nexstim Oyj  NXTMH.HE :
    * TO LICENSE TECHNOLOGY TO US-BASED MEDICAL TECHNOLOGY
COMPANY
MAGNUS MEDICAL, INC. FOR TREATMENT OF NEUROPSYCHIATRIC DISORDERS
    * STRUCTURE OF LICENSE AGREEMENT CONSISTS OF AN UPFRONT
PAYMENT OF
APPROXIMATELY USD 4 MILLION (APPROXIMATELY EUR 3.5 MILLION)
    * STRUCTURE OF LICENSE AGREEMENT INCLUDES, BASED ON MAGNUS
MEDICAL'S PROJECTED REVENUE, TECHNOLOGY ROYALTIES OF ABOUT USD
15 MILLION FOR PERIOD OF NOT EXCEEDING 5 YEARS
    * MINIMUM ROYALTY PAYMENTS AMOUNT TO ABOUT USD 1.2 MILLION
TO BE
PAID DURING FIRST THREE ROYALTY YEARS

Source text for Eikon:  ID:nGNE4zps35 
Further company coverage:  NXTMH.HE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Nexstim Oyj

See all news